Fig. 2
Changes in the mean CRT in patients with nAMD patients with brolucizumab every 6 weeks during induction therapy. The mean CRT was significantly improved after the first IVBr injection. CRT = central retinal thickness. **p < 1.0 × 10–20.
Fig. 2 | Scientific Reports
